Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci.

Diagnostic microbiology and infectious disease - 1 May 2016

Silva-Del Toro Stephanie L, Greenwood-Quaintance Kerryl E, Patel Robin

Abstract excerpt

The tedizolid MIC of 27 clinical isolates of linezolid-resistant staphylococci and enterococci was determined. Tedizolid MICs were ≥1μg/mL and were 4- to 32-fold lower than those of linezolid. Linezolid resistance mechanisms included G2576T 23S rRNA gene and rplC and rplD mutations.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Bacterial
Share to Enterococcus
Share to Linezolid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Organophosphates

Share to Oxazoles

Share to RNA, Ribosomal, 23S

Share to Staphylococcus

Source

Open in PubMed Open full text

Identifiers

PMID: 26971179
DOI: 10.1016/j.diagmicrobio.2016.02.008
PMCID: PMC8067670

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci.PMID 26971179Read ↗

Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.Semantic proximity Read ↗

Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and EuropeSemantic proximity Read ↗

Tedizolid for the Management of Human Infections: In Vitro CharacteristicsSemantic proximity Read ↗

Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typingSemantic proximity Read ↗

Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.Semantic proximity Read ↗

Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage.Semantic proximity Read ↗

In Vitro Activity of Tedizolid against Mycobacterium tuberculosisSemantic proximity Read ↗

Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.Semantic proximity Read ↗

New Gram-Positive Agents: the Next Generation of Oxazolidinones and LipoglycopeptidesSemantic proximity Read ↗

The oxazolidinones: past, present, and future.Semantic proximity Read ↗

Thrombocytopenia and Tedizolid: A new ally in hematologic patients? Brief literature review and a clinical caseSemantic proximity Read ↗

In vitro activity of linezolid against staphylococci.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.